Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma.

Chaichana KL, Pendleton C, Chambless L, Camara-Quintana J, Nathan JK, Hassam-Malani L, Li G, Harsh GR 4th, Thompson RC, Lim M, Quinones-Hinojosa A.

J Clin Neurosci. 2013 Oct;20(10):1422-6. doi: 10.1016/j.jocn.2013.02.007. Epub 2013 Aug 6.

2.

A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme.

Chaichana K, Parker S, Olivi A, Quiñones-Hinojosa A.

J Neurosurg. 2010 May;112(5):997-1004. doi: 10.3171/2009.9.JNS09805.

PMID:
19817542
3.

Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article.

Chaichana KL, Chaichana KK, Olivi A, Weingart JD, Bennett R, Brem H, Quiñones-Hinojosa A.

J Neurosurg. 2011 Mar;114(3):587-94. doi: 10.3171/2010.8.JNS1081. Epub 2010 Oct 1.

4.

A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma.

Park CK, Kim JH, Nam DH, Kim CY, Chung SB, Kim YH, Seol HJ, Kim TM, Choi SH, Lee SH, Heo DS, Kim IH, Kim DG, Jung HW.

Neuro Oncol. 2013 Aug;15(8):1096-101. doi: 10.1093/neuonc/not069. Epub 2013 Jun 25.

5.

Identifying better surgical candidates among recursive partitioning analysis class 2 patients who underwent surgery for intracranial metastases.

Chaichana KL, Acharya S, Flores M, Wijesekera O, Rigamonti D, Weingart JD, Olivi A, Bettegowda C, Gallia GL, Brem H, Lim M, Quinones-Hinojosa A.

World Neurosurg. 2014 Jul-Aug;82(1-2):e267-75. doi: 10.1016/j.wneu.2013.08.031. Epub 2013 Sep 25.

6.

Multiple resections for patients with glioblastoma: prolonging survival.

Chaichana KL, Zadnik P, Weingart JD, Olivi A, Gallia GL, Blakeley J, Lim M, Brem H, Quiñones-Hinojosa A.

J Neurosurg. 2013 Apr;118(4):812-20. doi: 10.3171/2012.9.JNS1277. Epub 2012 Oct 19.

7.

Scale to predict survival after surgery for recurrent glioblastoma multiforme.

Park JK, Hodges T, Arko L, Shen M, Dello Iacono D, McNabb A, Olsen Bailey N, Kreisl TN, Iwamoto FM, Sul J, Auh S, Park GE, Fine HA, Black PM.

J Clin Oncol. 2010 Aug 20;28(24):3838-43. doi: 10.1200/JCO.2010.30.0582. Epub 2010 Jul 19.

8.

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.

Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R.

J Neurosurg. 2001 Aug;95(2):190-8.

PMID:
11780887
9.

Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.

Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, Berger MS, Parsa AT.

J Neurosurg. 2012 Dec;117(6):1032-8. doi: 10.3171/2012.9.JNS12504. Epub 2012 Oct 5.

PMID:
23039151
10.

Prognostic value of ventricular wall fluorescence during 5-aminolevulinic-guided surgery for glioblastoma.

Tejada-Solís S, Aldave-Orzaiz G, Pay-Valverde E, Marigil-Sánchez M, Idoate-Gastearena MA, Díez-Valle R.

Acta Neurochir (Wien). 2012 Nov;154(11):1997-2002; discussion 2002. doi: 10.1007/s00701-012-1475-1. Epub 2012 Aug 29.

PMID:
22930281
11.

Survival prognostic factors in patients with glioblastoma: our experience.

Raysi Dehcordi S, De Paulis D, Marzi S, Ricci A, Cimini A, Cifone MG, Galzio RJ.

J Neurosurg Sci. 2012 Sep;56(3):239-45.

PMID:
22854592
12.

Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?

Nakamura H, Murakami R, Hirai T, Kitajima M, Yamashita Y.

Acta Radiol. 2013 Mar 1;54(2):214-20. doi: 10.1258/ar.2012.120525. Epub 2012 Nov 8.

PMID:
23138021
13.

Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias.

Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T; ALA-Glioma Study Group.

Neurosurgery. 2008 Mar;62(3):564-76; discussion 564-76. doi: 10.1227/01.neu.0000317304.31579.17.

PMID:
18425006
14.

Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy.

Kreth FW, Thon N, Simon M, Westphal M, Schackert G, Nikkhah G, Hentschel B, Reifenberger G, Pietsch T, Weller M, Tonn JC; German Glioma Network.

Ann Oncol. 2013 Dec;24(12):3117-23. doi: 10.1093/annonc/mdt388. Epub 2013 Oct 14.

15.

Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases.

Tait MJ, Petrik V, Loosemore A, Bell BA, Papadopoulos MC.

Br J Neurosurg. 2007 Oct;21(5):496-500.

PMID:
17852105
16.
17.

An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.

Oppenlander ME, Wolf AB, Snyder LA, Bina R, Wilson JR, Coons SW, Ashby LS, Brachman D, Nakaji P, Porter RW, Smith KA, Spetzler RF, Sanai N.

J Neurosurg. 2014 Apr;120(4):846-53. doi: 10.3171/2013.12.JNS13184. Epub 2014 Jan 31.

PMID:
24484232
18.

Efficacy of Surgery and Further Treatment of Progressive Glioblastoma.

Woernle CM, Péus D, Hofer S, Rushing EJ, Held U, Bozinov O, Krayenbühl N, Weller M, Regli L.

World Neurosurg. 2015 Aug;84(2):301-7. doi: 10.1016/j.wneu.2015.03.018. Epub 2015 Mar 19.

19.

Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery.

Aldave G, Tejada S, Pay E, Marigil M, Bejarano B, Idoate MA, Díez-Valle R.

Neurosurgery. 2013 Jun;72(6):915-20; discussion 920-1. doi: 10.1227/NEU.0b013e31828c3974.

PMID:
23685503
20.

Pre-Operative Perfusion Skewness and Kurtosis Are Potential Predictors of Progression-Free Survival after Partial Resection of Newly Diagnosed Glioblastoma.

Paik W, Kim HS, Choi CG, Kim SJ.

Korean J Radiol. 2016 Jan-Feb;17(1):117-26. doi: 10.3348/kjr.2016.17.1.117. Epub 2016 Jan 6.

Supplemental Content

Support Center